Minimally Invasive Surgery for Pancreatic Cancer

In recent years, Minimally Invasive Surgery (MIS) has revolutionized the way we treat pancreatic cancer and tumors. These advanced methods offer numerous benefits over traditional open surgery, such as smaller incisions, reduced pain and faster recovery times.Thanks to the precision of laparoscopic and robotic systems, surgeons can navigate the pancreas with enhanced accuracy, minimizing the risk of damage to surrounding organs and blood vessels. This level of precision not only improves surgical outcomes but also reduces complications and preserves the patient’s quality of life.

Clinical Background

1. Japan Society for Endoscopic Surgery (JSES): Introduction

2. Minimally Invasive Surgery for Pancreatic Cancer: Current Issues and Challenges - Prof. Yuichi Nagakawa (Japan)

3. Advances in Minimally Invasive Pancreatic Resection - Prof. Daisuke Ban (Japan)

4. MI Surgery for Pancreatic Tumors - Patient Outcomes - Prof. Ugo Boggi (Italy)

5. Panel Discussion - All faculty moderated by Prof. Yuichi Nagakawa (Japan)

6. Closing Remarks - Prof. Yuichi Nagakawa (Japan)